|
1
|
Anderson FA Jr, Wheeler HB, Goldberg RJ,
et al: A population-based perspective of the hospital incidence and
case-fatality rates of deep vein thrombosis and pulmonary embolism.
The Worcester DVT Study. Arch Intern Med. 151:933–938. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brown HL and Hiett AK: Deep vein
thrombosis and pulmonary embolism in pregnancy: diagnosis,
complications, and management. Clin Obstet Gynecol. 53:345–359.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jaff MR, McMurtry MS, Archer SL, et al:
Management of massive and submassive pulmonary embolism,
iliofemoral deep vein thrombosis, and chronic thromboembolic
pulmonary hypertension: a scientific statement from the American
Heart Association. Circulation. 123:1788–1830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hardwick ME, Pulido PA and Colwell CW Jr:
A mobile compression device compared with low-molecular-weight
heparin for prevention of venous thromboembolism in total hip
arthroplasty. Orthop Nurs. 30:312–316. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Orken DN, Kenangil G, Ozkurt H, et al:
Prevention of deep venous thrombosis and pulmonary embolism in
patients with acute intracerebral hemorrhage. Neurologist.
15:329–331. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lawless RA and Dangleben DA: Caval
agenesis with a hypoplastic left kidney in a patient with trauma on
warfarin for deep vein thrombosis. Vasc Endovascular Surg.
46:75–76. 2012. View Article : Google Scholar
|
|
7
|
Battistelli S, Genovese A and Gori T:
Heparin-induced thrombocytopenia in surgical patients. Am J Surg.
199:43–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scarpa M, Pilon F, Pengo V, et al: Deep
venous thrombosis after surgery for inflammatory bowel disease: is
standard dose low molecular weight heparin prophylaxis enough?
World J Surg. 34:1629–1636. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu S, Zhong B, Zheng M, Xiao F, Dong Z and
Zhang H: The quality of randomized controlled trials on DanShen in
the treatment of ischemic vascular disease. J Altern Complement
Med. 15:557–565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng TO: Cardiovascular effects of
Danshen. Int J Cardiol. 121:9–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ho JH and Hong CY: Salvianolic acids:
small compounds with multiple mechanisms for cardiovascular
protection. J Biomed Sci. 18:302011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iverson RE and Gomez JL: Deep venous
thrombosis: prevention and management. Clin Plast Surg. 40:389–398.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang YP, Zhang XQ, Yu WN, et al:
Endovascular treatment of acute proximal deep venous thrombosis
secondary to iliac vein compression syndrome: a novel technique for
thrombus removal. Chin Med J (Engl). 126:3184–3186. 2013.
|
|
14
|
Deep venous thrombosis and pulmonary
embolism. Part 1. Initial treatment: usually a low-molecular-weight
heparin. Prescrire Int. 22:99–101. 103–104. 2013.PubMed/NCBI
|
|
15
|
Cho ES, Chung JJ, Kim S, Kim JH, Yu JS and
Yoon CS: CT venography for deep vein thrombosis using a low tube
voltage (100 kVp) setting could increase venous enhancement and
reduce the amount of administered iodine. Korean J Radiol.
14:183–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liew A and Douketis J: Initial and
long-term treatment of deep venous thrombosis: recent clinical
trials and their impact on patient management. Expert Opin
Pharmacother. 14:385–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wen XD, Wang CZ, Yu C, et al: Salvia
miltiorrhiza (dan shen) significantly ameliorates colon
inflammation in dextran sulfate sodium induced colitis. Am J Chin
Med. 41:1097–1108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang JP, Zhang YY, Zhang Y, et al: Salvia
miltiorrhiza (Danshen) injection ameliorates iron overload-induced
cardiac damage in mice. Planta Med. 79:744–752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gurbel PA, Serebruany VL, Shustov AR, et
al: Increased baseline levels of platelet P-selectin, and
platelet-endothelial cell adhesion molecule-1 in patients with
acute myocardial infarction as predictors of unsuccessful
thrombolysis. Coron Artery Dis. 9:451–456. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han JY, Fan JY, Horie Y, et al:
Ameliorating effects of compounds derived from Salvia miltiorrhiza
root extract on microcirculatory disturbance and target organ
injury by ischemia and reperfusion. Pharmacol Ther. 117:280–295.
2008. View Article : Google Scholar
|
|
21
|
Arbring K, Uppugunduri S and Lindahl TL:
Comparison of prothrombin time (INR) results and main
characteristics of patients on warfarin treatment in primary health
care centers and anticoagulation clinics. BMC Health Serv Res.
13:852013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Axtell AL1, Gomari FA and Cooke JP:
Assessing endothelial vasodilator function with the Endo-PAT 2000.
J Vis Exp. 15:21672010.
|
|
23
|
Luscher TF and Barton M: Biology of the
endothelium. Clin Cardiol. 20:II-3–10. 1997.
|
|
24
|
Ling S, Nheu L, Dai A, Guo Z and
Komesaroff P: Effects of four medicinal herbs on human vascular
endothelial cells in culture. Int J Cardiol. 128:350–358. 2008.
View Article : Google Scholar
|
|
25
|
Zhou Z, Wang SQ, Liu Y and Miao AD:
Cryptotanshinone inhibits endothelin-1 expression and stimulates
nitric oxide production in human vascular endothelial cells.
Biochim Biophys Acta. 1760:1–9. 2006. View Article : Google Scholar
|
|
26
|
Chan P, Chen YC, Lin LJ, Cheng TH, Anzai
K, Chen YH, Liu ZM, Lin JG and Hong HJ: Tanshinone IIA attenuates
H2O2-induced injury in human umbilical vein
endothelial cells. Am J Chin Med. 40:1307–1319. 2012. View Article : Google Scholar
|
|
27
|
Zhou ZW, Xie XL, Zhou SF and Li CG:
Mechanism of reversal of high glucose-induced endothelial nitric
oxide synthase uncoupling by tanshinone IIA in human endothelial
cell line EA.hy926. Eur J Pharmacol. 697:97–105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Møller P, Danielsen PH, Karottki DG,
Jantzen K, Roursgaard M, Klingberg H, Jensen DM, Christophersen DV,
Hemmingsen JG, Cao Y and Loft S: Oxidative stress and inflammation
generated DNA damage by exposure to air pollution particles. Mutat
Res Rev Mutat Res. 762C:133–166. 2014. View Article : Google Scholar
|
|
29
|
Chan K, Lo AC, Yeung JH and Woo KS: The
effects of Danshen (Salvia miltiorrhiza) on warfarin
pharmacodynamics and pharmacokinetics of warfarin enantiomers in
rats. J Pharm Pharmacol. 47:402–406. 1995. View Article : Google Scholar : PubMed/NCBI
|
